Carbamazepine Tablet, Extended Release
Product Images NDC 0832-6024
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 0832-6024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (100 mg Tablet Bottle Label)
Principal Display Panel (200 mg Tablet Bottle Label)
Principal Display Panel (400 mg Tablet Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.